Nachrichten zur ANI Pharmaceuticals Inc. Aktie

ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET

BAUDETTE, Minn., April 18, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today…

Nika Pharmaceuticals, Inc. (NKPH) Purchased the Technologies for Three Drugs in Tablet Form and One Dietary Supplement

Nika Pharmaceuticals, Inc. (NKPH) announces the purchase of technologies for production of three generic drugs in tablet form and one…

GMAB: 3 Biotech Stocks Gaining Altitude and Interest

This year, the biotech industry anticipates a resurgence with increased M&A, FDA approvals, and AI-driven innovations. Given the industry’s rosy…

Nika Pharmaceuticals, Inc. (NKPH) Merges With Nika Biotechnology, Inc.

Nika Pharmaceuticals, Inc. (OTCMKTS: NKPH) announces its merger with Nika BioTechnology, Inc., effective as of March 1, 2024.…

ANI Pharmaceuticals, Inc. (ANIP) Q4 2023 Earnings Call Transcript

…

ANI Pharmaceuticals to present at Leerink Biopharma Conference By Investing.com

ANI Pharmaceuticals to present at Leerink Biopharma Conference…

Aurinia Pharmaceuticals Inc. (AUPH) Q4 2023 Earnings Call Transcript

…

ANI Pharmaceuticals Announces the Launch of Pentoxifylline Extended-Release Tablets, USP

BAUDETTE, Minn., Jan. 23, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today…

ANI Pharmaceuticals: A New Assessment

…

BUSINESS WIRE: Nordic Pharma Group B.V. schließt über ihre Tochtergesellschaft Amring Pharmaceuticals Inc. die Übernahme von Visant Medical ab, um in den Vereinigten Staaten eine neuartige Therapie für trockene Augen einzuführen

MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.BERWYN, Pennsylvania --(BUSINESS WIRE)-- 18.12.2023 --Amring Pharmaceuticals…

Branded Legacy, Inc. (BLEG) Expands Portfolio with Comprehensive Acquisition of MariJ Pharmaceuticals Inc, Including Licenses, Organic Certifications, and Substantial Assets

Acquisition marks the largest acquisition to date with multi-state processing licenses, compounding pharmacy license, and advanced equipment Acquisition marks the…

Global Non-Hodgkin Lymphoma Therapeutics Market Size To Worth USD 16.64 Billion by 2032 | CAGR of 7.8%

The Global Non-Hodgkin Lymphoma Therapeutics Market Size was valued at USD 7.85 Billion in 2022. The Worldwide Non-Hodgkin Lymphoma Therapeutics…

ANI Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference

BAUDETTE, Minn., Nov. 22, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today…

Vanda Pharmaceuticals Inc. (VNDA) Q3 2023 Earnings Call Transcript

…

ANI Pharmaceuticals, Inc. (ANIP) Q3 2023 Earnings Call Transcript

…

Aurinia Pharmaceuticals Inc. (AUPH) Q3 2023 Earnings Call Transcript

…

ANI Pharmaceuticals to Discuss Third Quarter 2023 Financial Results on November 8, 2023, at 8:30 a.m. ET

BAUDETTE, Minn., Oct. 25, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today…

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Tablets USP

BAUDETTE, Minn., Sept. 12, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today…

ANI Pharmaceuticals Announces Approval, Launch Of Estradiol Gel, 0.1%

WASHINGTON (dpa-AFX) - ANI Pharmaceuticals, Inc. (ANIP) received U.S. Food and Drug Administration approval for the Abbreviated New Drug Application…

ANI Pharma granted FDA nod for generic Estradiol Gel

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ANI Pharmaceuticals Gets FDA Approval For Estradiol Gel

ANI Pharmaceuticals Gets FDA Approval For Estradiol Gel...…

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.1%

BAUDETTE, Minn., Aug. 28, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today…

ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

BAUDETTE, Minn., Aug. 24, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today…

ANI Pharmaceuticals Appoints Healthcare Executive Matthew J. Leonard to its Board of Directors

-- Mr. Leonard is an accomplished leader with 35 years of pharmaceuticals and healthcare experience...…

Form 8-K ANI PHARMACEUTICALS INC For: Aug 21

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: HEAD OF R&D, COO-NOVITIUM OPS verkauft Aktien von ANI Pharmaceuticals im Wert von 1.361.976$

Shanmugam, Muthusamy - Vorstand - Tag der Transaktion: 2023-08-15...…

Insiderhandel: HEAD OF R&D, COO-NOVITIUM OPS verkauft Aktien von ANI Pharmaceuticals im Wert von 1.705.474$

Shanmugam, Muthusamy - Vorstand - Tag der Transaktion: 2023-08-14...…

Insiderhandel: Insider verkauft Aktien von ANI Pharmaceuticals im Wert von 11.700.000$

Meridian Venture Partners II Lp - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2023-08-16...…

Is Amphastar Pharmaceuticals (AMPH) Stock Outpacing Its Medical Peers This Year?

Here is how Amphastar Pharmaceuticals (AMPH) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year....…

ANI Pharmaceuticals (ANIP) Beats Q2 Earnings and Revenue Estimates

ANI (ANIP) delivered earnings and revenue surprises of 100% and 20.41%, respectively, for the quarter ended June 2023. Do the…

ANI Pharmaceuticals, Inc. Q2 Earnings Summary

WASHINGTON (dpa-AFX) - Below are the earnings highlights for ANI Pharmaceuticals, Inc. (ANIP):Earnings: $5.84 million in Q2 vs. -$15.33 million…

Form 10-Q ANI PHARMACEUTICALS INC For: Jun 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

ANI Pharmaceuticals Non-GAAP EPS of $1.28 beats by $0.61, revenue of $116.5M beats by $16.64M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K ANI PHARMACEUTICALS INC For: Aug 09

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

ANI Pharmaceuticals Reports Record Second Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance

Second Quarter 2023 Financial Results...…

ANI Pharmaceuticals Q2 2023 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ANI Pharmaceuticals to Discuss Second Quarter 2023 Financial Results on August 9, 2023, at 8:30 a.m. ET

BAUDETTE, Minn., July 31, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today…

ANI Pharmaceuticals (ANIP) Outpaces Stock Market Gains: What You Should Know

ANI Pharmaceuticals (ANIP) closed the most recent trading day at $52.79, moving +1.15% from the previous trading session....…

Insiderhandel: HEAD OF R&D, COO-NOVITIUM OPS verkauft Aktien von ANI Pharmaceuticals im Wert von 309.120$

Shanmugam, Muthusamy - Vorstand - Tag der Transaktion: 2023-07-20...…

Insiderhandel: HEAD OF R&D, COO-NOVITIUM OPS verkauft Aktien von ANI Pharmaceuticals im Wert von 307.284$

Shanmugam, Muthusamy - Vorstand - Tag der Transaktion: 2023-07-19...…

Insiderhandel: HEAD OF R&D, COO-NOVITIUM OPS verkauft Aktien von ANI Pharmaceuticals im Wert von 604.440$

Shanmugam, Muthusamy - Vorstand - Tag der Transaktion: 2023-07-21...…

Where ANI Pharmaceuticals Stands With Analysts

Latest Ratings for ANIP DateFirmActionFromTo Nov 2021Raymond JamesMaintainsOutperform Nov 2021Truist SecuritiesInitiates Coverage OnBuy May 2021Raymond JamesMaintainsOutperform …